Old Drugs, New Tricks: The Power of Medication Repurposing COVID highlighted the untapped potential of existing treatments Oct 30, 2024
IG Live November 1: Healthcare Is on the Ballot Public health and access to care are at stake in the 2024 election Oct 30, 2024
Could RFK Jr. Really Become HHS Secretary? It seems unlikely, but Washington insiders say they've come to expect the unexpected Oct 29, 2024
AirPods' Hearing Aid Feature Could Help People Face a Problem They'd Rather Ignore Apple's new feature can boost voices, media, and phone calls, and maybe lessen stigma Oct 29, 2024
A Look at the Supreme Court's Upcoming Term Public health is on the chopping block once again Oct 28, 2024
FDA Approves Novel Treatment for UTIs New oral antibiotic gets a nod for uncomplicated urinary tract infections Oct 25, 2024
Ob/Gyn Attack Caught on Tape; Antidepressant Recall; Onions Eyed as E. Coli Source Health news and commentary gathered by ľֱ staff Oct 25, 2024
FDA Warns Companies Over Products Made With Amniotic Fluid Agency says PalinGen products are unapproved drugs Oct 24, 2024
Approval of Bevacizumab Biosimilar for Ophthalmic Use Could Upend Low-Cost Anti-VEGF Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost Oct 24, 2024
FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults Decision was based on need for RSV protection in younger people with chronic conditions Oct 23, 2024
What Will the IV Fluid Shortage Mean for Hospital Finance? A more strategic approach to production is key to preventing crises like this Oct 23, 2024
Novel Targeted Drug Approved for Stomach Cancers Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy Oct 18, 2024
Drugmaker Pulls Trodelvy's Bladder Cancer Approval In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy Oct 18, 2024
Serious Battery Issue Prompts Medtronic Insulin Pump Recall Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
Continuous Parkinson's Disease Therapy Wins FDA Nod Round-the-clock infusion delivers carbidopa and levodopa pro-drugs Oct 17, 2024
Three States Renew Effort to Reduce Access to Abortion Pill Mifepristone Lawsuit aims to require three in-person doctor visits, bar drug's use after 7 weeks of pregnancy Oct 17, 2024
The Supreme Court's Open Season on Public Health Agencies "I just had this reverence for the court. I don't anymore," says Lawrence Gostin, JD Oct 16, 2024 video
Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers During harvesting and processing, the seeds can become coated with the opium Oct 12, 2024
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors First once-weekly subcutaneous prophylactic option for hemophilia B Oct 11, 2024
Elamipretide for Barth Syndrome Survives FDA Advisory Vote Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease Oct 10, 2024
FDA's Promised Guidance on Pulse Oximeters Unlikely to End Decades of Racial Bias Devices three times as likely to miss dangerously low blood oxygen in Black patients Oct 10, 2024
FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndrome Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease Oct 09, 2024
How Did Public Health Become a Public Enemy at the Supreme Court? Conservative majority is "buying into" anti-science attitudes, warns Lawrence Gostin, JD Oct 09, 2024 video
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved? I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
Judge Rules Against Stem Cell Clinic Two federal court decisions now hold that fat-derived stem cell treatment is a drug Oct 02, 2024
Elevating Family Medicine Is Key for New AAFP President Jen Brull, MD, outlines her priorities for the coming year Oct 01, 2024
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1 Sep 27, 2024
First-Ever Biologic Approved for COPD Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations Sep 27, 2024
FDA Approves First Novel Drug for Schizophrenia in Decades Xanomeline and trospium chloride (Cobenfy) has no boxed warnings Sep 27, 2024
Sickle Cell Disease Drug Pulled From Global Markets Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
FDA Expands Approval of Osimertinib in Lung Cancer EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
Second Drug OK'd for Ultra-Rare Neurodegenerative Disease FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C Sep 25, 2024
IG Live September 27: Court Adjourned, Healthcare Overturned Decoding recent SCOTUS decisions and their potential impact on healthcare Sep 25, 2024
Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1% Sep 24, 2024
FDA OKs First Flu Vaccine for At-Home Use FluMist nasal spray can now be used without the help of a healthcare provider Sep 20, 2024
First Drug Approved for Niemann-Pick Disease Type C Arimoclomol (Miplyffa) greenlit for ultra-rare genetic disorder Sep 20, 2024
FDA Rejects NK1R Antagonist for Gastroparesis Drugmaker none-too-pleased with agency's request for additional studies Sep 19, 2024
FDA OKs New Option for Rare Immune-Mediated Vasculitis Benralizumab wins approval for eosinophilic granulomatosis with polyangiitis Sep 18, 2024
FDA Expands Approval of Ribociclib to Early Breast Cancer Broad indication doubles the number of patients eligible for adjuvant CDK4/6 inhibition Sep 17, 2024